Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non–small cell lung cancer
JA Engelman, PA Jänne - Clinical Cancer Research, 2008 - AACR
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors gefitinib and erlotinib are
effective therapies for non–small cell lung cancer patients whose tumors harbor somatic …
effective therapies for non–small cell lung cancer patients whose tumors harbor somatic …
Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
JA Engelman, PA Jänne - Clinical cancer research: an …, 2008 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors gefitinib and erlotinib are
effective therapies for non-small cell lung cancer patients whose tumors harbor somatic …
effective therapies for non-small cell lung cancer patients whose tumors harbor somatic …
[PDF][PDF] Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non^ Small Cell Lung Cancer
researchgate.net
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors gefitinib and erlotinib are
effective therapies for non^ small cell lung cancer patients whose tumors harbor somatic …
effective therapies for non^ small cell lung cancer patients whose tumors harbor somatic …
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer
JA Engelman, PA Jänne - Clinical Cancer Research, 2008 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitors gefitinib and erlotinib are effective therapies for non–small cell …
tyrosine kinase inhibitors gefitinib and erlotinib are effective therapies for non–small cell …
Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
JA Engelman, PA Jänne - … Cancer Research: an Official Journal of …, 2008 - europepmc.org
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors gefitinib and erlotinib are
effective therapies for non-small cell lung cancer patients whose tumors harbor somatic …
effective therapies for non-small cell lung cancer patients whose tumors harbor somatic …